Fol. Biol. 2010, 56, 206-210

https://doi.org/10.14712/fb2010056050206

Th1/Th2 Cytokine Gene Polymorphisms in Patients With Uterine Fibroid

O. Sosna1, Libor Kolesár2, A. Slavčev2, J. Skibová3, T. Fait1, M. Mara1, I. Stříž4, D. Kužel1

1Charles University in Prague, First Faculty of Medicine and General University Hospital, Department of Gynaecology and Obstetrics, Prague, Czech Republic
2Institute for Clinical and Experimental Medicine, Department of Immunogenetics, Prague, Czech Republic
3Institute for Clinical and Experimental Medicine, Department of Medical Statistics, Prague, Czech Republic
4Institute for Clinical and Experimental Medicine, Department of Clinical and Transplant Immunology, Prague, Czech Republic

Received April 2010
Accepted May 2010

References

1. Andersen, T. I., Heimdal, K. R., Skrede, M., Tveit, K., Berg, K., Borresen, A. L. (1994) Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum. Genet. 94, 665-670.
2. Arici, A., Sozen, I. (2000) Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil. Steril. 73, 1006-1011. <https://doi.org/10.1016/S0015-0282(00)00418-0>
3. Blankenstein, T. (2005) The role of tumor stroma in the interaction between tumor and immune system. Curr. Opin. Immunol. 17, 180-186. <https://doi.org/10.1016/j.coi.2005.01.008>
4. Chouchane, L., Ahmed, S. B., Baccouche, S., Remadi, S. (1997) Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 80, 1489-1496. <https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1>
5. Evans, P., Brunsell, S. (2007) Uterine fibroid tumors: diagnosis and treatment. Am. Fam. Physician 75, 1503-1508.
6. Falcone, T., Walters, M. D. (2008) Hysterectomy for benign disease. Obstet. Gynecol. 111, 753-767. <https://doi.org/10.1097/AOG.0b013e318165f18c>
7. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., Woo, P. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102, 1369-1376. <https://doi.org/10.1172/JCI2629>
8. Flake, G. P., Andersen, J., Dixon, D. (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ. Health Perspect. 111, 1037-1054. <https://doi.org/10.1289/ehp.5787>
9. Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M., Pardoll, D. M. (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254, 713-716. <https://doi.org/10.1126/science.1948050>
10. Hock, H., Dorsch, M., Kunzendorf, U., Qin, Z., Diamantstein, T., Blankenstein, T. (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon γ. Proc. Natl. Acad. Sci. USA 90, 2774-2778. <https://doi.org/10.1073/pnas.90.7.2774>
11. Hock, H., Dorsch, M., Richter, G., Kunzendorf, U., KrugerKrasagakes, S., Blankenstein, T., Qin, Z., Diamantstein, T. (1994) Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy. Nat. Immun. 13, 85-92.
12. Hsieh, Y. Y., Chang, C. C., Tsai, F. J., Lin, C. C., Yeh, L. S., Tsai, C. H. (2004) Tumor necrosis factor-α-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas. Fertil. Steril. 82 Suppl 3, 1177-1181. <https://doi.org/10.1016/j.fertnstert.2004.03.035>
13. Hsieh, Y. Y., Chang, C. C., Tsai, C. H., Lin, C. C., Tsai, F. J. (2007) Interleukin (IL)-12 receptor β1 codon 378 G homozygote and allele, but not IL-1 (β-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil. Steril. 87, 886-895. <https://doi.org/10.1016/j.fertnstert.2006.07.1541>
14. Inagaki, N., Ung, L., Otani, T., Wilkinson, D., Lopata, A. (2003) Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur. J. Obstet. Gynecol. Reprod. Biol. 111, 197-203. <https://doi.org/10.1016/S0301-2115(03)00244-6>
15. Litovkin, K. V., Domenyuk, V. P., Bubnov, V. V., Zaporozhan, V. N. (2007) Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study. Exp. Oncol. 29, 295-298.
16. Maruo, T., Matsuo, H., Shimomura, Y., Kurachi, O., Gao, Z., Nakago, S., Yamada, T., Chen, W., Wang, J. (2003) Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids 68, 817-824. <https://doi.org/10.1016/j.steroids.2003.08.017>
17. Parker, W. H. (2007) Etiology, symptomatology, and diagnosis of uterine myomas. Fertil. Steril. 87, 725-736. <https://doi.org/10.1016/j.fertnstert.2007.01.093>
18. Pietrowski, D., Thewes, R., Sator, M., Denschlag, D., Keck, C., Tempfer, C. (2009) Uterine leiomyoma is associated with a polymorphism in the interleukin 1-β gene. Am. J. Reprod. Immunol. 62, 112-117. <https://doi.org/10.1111/j.1600-0897.2009.00718.x>
19. Rosenwasser, L. J., Borish, L. (1997) Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am. J. Respir. Crit. Care Med. 156, S152-S155. <https://doi.org/10.1164/ajrccm.156.4.12tac-14>
20. Shimomura, Y., Matsuo, H., Samoto, T., Maruo, T. (1998) Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J. Clin. Endocrinol. Metab. 83, 2192-2198.
21. Skorpil, N., Kolesár, L., Striz, I., Lardy, N. M., Slavcev, A. (2007) Cytokine gene polymorphisms in the Dutch population. Int. J. Immunogenet. 34, 87-90. <https://doi.org/10.1111/j.1744-313X.2007.00663.x>
22. Smith, A. J., Humphries, S. E. (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 20, 43-59. <https://doi.org/10.1016/j.cytogfr.2008.11.006>
23. Stewart, E. A., Morton, C. C. (2006) The genetics of uterine leiomyomata: what clinicians need to know. Obstet. Gynecol. 107, 917-921. <https://doi.org/10.1097/01.AOG.0000206161.84965.0b>
24. Syssoev, K. A., Kulagina, N. V., Chukhlovin, A. B., Morozova, E. B., Totolian, A. A. (2008) Expression of mRNA for chemokines and chemokine receptors in tissues of the myometrium and uterine leiomyoma. Bull. Exp. Biol. Med. 145, 84-89. <https://doi.org/10.1007/s10517-008-0038-1>
25. Tepper, R. I., Pattengale, P. K., Leder, P. (1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57, 503-512. <https://doi.org/10.1016/0092-8674(89)90925-2>
26. Turner, D., Grant, S. C., Yonan, N., Sheldon, S., Dyer, P. A., Sinnott, P. J., Hutchinson, I. V. (1997) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779. <https://doi.org/10.1097/00007890-199709150-00021>
27. Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., Duff, G. W. (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94, 3195-3199. <https://doi.org/10.1073/pnas.94.7.3195>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive